Invuity
ProfileJobs (10)

Invuity

Suggest Edit
    • Healthcaremedical devicessurgical solutionsvisual

    Invuity is a medical technology company focused on pioneering the use of advanced photonics to provide surgeons with improved direct visualization of surgical cavities during open minimally invasive and minimal access procedures. The Company's patented Intelligent Photonics technology enables superior illumination and visualization and is designed to overcome the significant limitations of traditional surgical lighting options in the operating room.

    Invuity's patented Intelligent Photonics is integrated into the Company's single-use and reusable advanced surgical devices to address some of the critical intracavity illumination and visualization challenges facing surgeons today. These devices utilize Invuity's proprietary optical waveguide technology to direct and shape thermally cool, brilliant light into broad, uniform and volumetric illumination of the surgical target.

    Revenue(FY, 2017)
    $39.6 M
    Market capitalization(2018-09-20)
    $176.9 M
    TypePublic
    HQSan Francisco, US
    Founded2004
    Size (employees)174 (est)+54%
    Websiteinvuity.com
    Invuity was founded in 2004 and is headquartered in San Francisco, US
    Report incorrect company information

    Viewing summary data as a guest

    Sign up for free to see all data

    Key People/Management at Invuity

    Scott Flora

    Scott Flora

    Interim President and Chief Executive Officer
    James H. Mackaness

    James H. Mackaness

    CFO
    Doug Heigel

    Doug Heigel

    Senior Vice President of Operations
    Steve Annen

    Steve Annen

    Vice President of Product Management and Strategy
    Sham Shiblaq

    Sham Shiblaq

    Vice President of Commercial Operations
    Lauren Budesheim

    Lauren Budesheim

    Senior Director, Human Resources
    Show more

    Invuity Office Locations

    Invuity has offices in Baltimore, Phoenix, San Antonio, St. Louis and in 9 other locations
    San Francisco, US (HQ)
    444 De Haro St
    Show all (13)
    Report incorrect company information

    Invuity Financials and Metrics

    Invuity Revenue

    Invuity's revenue was reported to be $39.62 m in FY, 2017
    USD

    Revenue (Q2, 2018)

    		20 m

    Gross profit (Q2, 2018)

    		13 m

    Gross profit margin (Q2, 2018), %

    		65%

    EBIT (Q2, 2018)

    		(18.6 m)

    Market capitalization (20-Sep-2018)

    		176.9 m

    Closing stock price (20-Sep-2018)

    		7.4

    Cash (30-Jun-2018)

    		15.3 m

    EV

    		186.2 m
    Invuity's current market capitalization is $176.9 m.
    Annual
    USDFY, 2015FY, 2016FY, 2017

    Revenue

    		21 m32.5 m39.6 m

    Revenue growth, %

    		54%

    Cost of goods sold

    		7.7 m8.8 m11.7 m

    Gross profit

    		13.3 m23.6 m27.9 m
    Quarterly
    USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

    Revenue

    		4.7 m5.6 m6.4 m8.2 m8.5 m9 m9.8 m9.6 m9.5 m20 m

    Cost of goods sold

    		1.9 m2 m2.1 m2.1 m2.2 m2.1 m3 m2.9 m2.9 m7 m

    Gross profit

    		2.8 m3.6 m4.3 m6.1 m6.3 m6.9 m6.8 m6.7 m6.6 m13 m

    Gross profit Margin, %

    		59%64%67%75%74%77%69%70%69%65%
    show all
    Annual
    USDFY, 2015FY, 2016FY, 2017

    Cash

    		46.3 m28.3 m18 m

    Accounts Receivable

    		3.6 m5.8 m7.4 m

    Inventories

    		923 k1.1 m7.4 m

    Current Assets

    		56 m51.1 m37.3 m
    Quarterly
    USDQ3, 2017Q1, 2018Q2, 2018

    Cash

    		29.5 m15.3 m

    Accounts Receivable

    		6.2 m6.3 m6.7 m

    Inventories

    		1.6 m8.7 m8.5 m

    Current Assets

    		48.9 m40.9 m
    show all
    Annual
    USDFY, 2015FY, 2016FY, 2017

    Net Income

    		(37.6 m)(40.6 m)(39.9 m)

    Depreciation and Amortization

    		1.7 m2 m2 m

    Inventories

    		1.6 m130 k(2.4 m)

    Accounts Payable

    		1.3 m(284 k)1.4 m
    Quarterly
    USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

    Net Income

    		(11.2 m)

    Depreciation and Amortization

    		365 k

    Inventories

    		4.8 m4.9 m5.6 m5.5 m5.1 m5.9 m5.6 m1.6 m(1.3 m)

    Accounts Payable

    		2 m1.1 m1.8 m2.4 m2.8 m3.3 m2.9 m3.5 m(388 k)
    show all
    USDY, 2018

    EV/EBIT

    		-10 x

    EV/CFO

    		-21.9 x

    Financial Leverage

    		20.9 x
    Show all financial metrics

    Invuity Operating Metrics

    FY, 2016

    Facilities

    		1

    Patent Applications

    		46

    Products

    		40

    Trademarks

    		38
    Show all operating metrics
    Report incorrect company information

    Competitors

    Bionic Vision Technologies
    Healthcare - Private
    Arthrex
    Healthcare - Private
    VertiFlex
    Healthcare - Private
    REVA Medical
    Healthcare - Public
    Compare competitors

    Invuity Online and Social Media Presence

    Embed Graph
    Report incorrect company information

    Invuity News and Updates

    September 20, 2018

    WeissLaw LLP Investigates Invuity, Inc. Acquisition

    NEW YORK, Sept. 20, 2018 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Invuity, Inc. ("IVTY" or the "Company") (NASDAQ: IVTY) in connection with the proposed acquisition of the Company by Stryker...
    September 13, 2018

    RM LAW Announces Investigation of Invuity, Inc.

    BERWYN, Pa., Sept. 13, 2018 /PRNewswire/ -- RM LAW, P.C. is investigating potential claims against the board of directors of Invuity, Inc. ("Invuity" or the "Company") (NASDAQ: IVTY) concerning possible breaches of fiduciary duty and other violations of law related to the Company's...
    September 12, 2018

    SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Invuity, Inc. - IVTY

    NEW YORK, Sept. 12, 2018 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Invuity, Inc. ("Invuity" or the "Company") (NasdaqGM: IVTY)...
    September 11, 2018

    ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Invuity, Inc.

    NEW YORK, Sept. 11, 2018 /PRNewswire/ -- Rowley Law PLLC is investigating potential claims against Invuity, Inc. (NASDAQ: IVTY) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Stryker Corporation. Stockholders will receive...
    September 11, 2018

    Invuity (IVTY) Alert: Johnson Fistel Investigates Proposed Sale of Invuity, Inc.; Is $ $7.40 a Fair Price?

    SAN DIEGO, Sept. 11, 2018 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Invuity, Inc. (NASDAQ: IVTY) ("Invuity") breached their fiduciary duties in connection with the proposed sale of the Company to Stryker ...
    September 11, 2018

    Invuity Announces Definitive Agreement to Be Acquired by Stryker Corporation for $7.40 Per Share in Cash

    SAN FRANCISCO, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY), a leading medical technology company focused on advanced surgical devices to enable better visualization, today announced it has entered into a definitive agreement with Stryker Corporation (NYSE:SYK), pursuant to whic…
    Show more
    Report incorrect company information

    Invuity Company Life and Culture

    Report incorrect company information
    Download PDF